Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
暂无分享,去创建一个
A. Fiorelli | G. Vicidomini | M. Santini | N. Normanno | F. Ciardiello | L. Berrino | C. D. Della Corte | G. Viscardi | F. Papaccio | G. Esposito | F. Morgillo | F. C. Sasso | M. Fasano | A. Capuano | R. Di Liello